Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2014, Article ID 847162, 7 pages
http://dx.doi.org/10.1155/2014/847162
Research Article

Modeling the Relationship between Fluorodeoxyglucose Uptake and Tumor Radioresistance as a Function of the Tumor Microenvironment

The Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA

Received 4 July 2014; Accepted 25 August 2014; Published 8 September 2014

Academic Editor: Iuliana Toma-Dasu

Copyright © 2014 Jeho Jeong and Joseph O. Deasy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Ido, C.-N. Wan, and V. Casella, “Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-deoxy-2-fluoro-D-glucose,” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 14, no. 2, pp. 175–183, 1978. View at Publisher · View at Google Scholar · View at Scopus
  2. M. H. M. Janssen, H. J. W. L. Aerts, M. C. Öllers et al., “Tumor delineation based on time-activity curve differences assessed with dynamic fluorodeoxyglucose positron emission tomography-computed tomography in rectal cancer patients,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 2, pp. 456–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Ben-Haim and P. Ell, “18F-FDG PET and PET/CT in the evaluation of cancer treatment response,” Journal of Nuclear Medicine, vol. 50, no. 1, pp. 88–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Xie, M. Li, H. Zhao, X. Sun, Z. Fu, and J. Yu, “18F-FDG PET or PET-CT to evaluate prognosis for head and neck cancer: a meta-analysis,” Journal of Cancer Research and Clinical Oncology, vol. 137, no. 7, pp. 1085–1093, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Ghooshkhanei, G. Treglia, G. Sabouri, R. Davoodi, and R. Sadeghi, “Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis,” Gynecologic Oncology, vol. 132, no. 3, pp. 669–676, 2014. View at Publisher · View at Google Scholar
  6. K. Pak, G. J. Cheon, H. Y. Nam et al., “Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis,” Journal of Nuclear Medicine, vol. 55, no. 6, pp. 884–890, 2014. View at Google Scholar
  7. Z. Wang, J.-Q. Chen, J.-L. Liu, X.-G. Qin, and Y. Huang, “FDG-PET in diagnosis, staging and prognosis of pancreatic carcinoma: a meta-analysis,” World Journal of Gastroenterology, vol. 19, no. 29, pp. 4808–4817, 2013. View at Publisher · View at Google Scholar
  8. M. Feng, F.-M. Kong, M. Gross, S. Fernando, J. A. Hayman, and R. K. Ten Haken, “Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing,” International Journal of Radiation Oncology Biology Physics, vol. 73, no. 4, pp. 1228–1234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. de Ruysscher, S. Wanders, A. Minken et al., “Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study,” Radiotherapy and Oncology, vol. 77, no. 1, pp. 5–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Jeong, J. S. Setton, N. Y. Lee, J. H. Oh, and J. O. Deasy, “Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control,” Radiotherapy and Oncology, vol. 111, no. 3, pp. 340–347, 2014. View at Publisher · View at Google Scholar
  11. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Gatenby and R. J. Gillies, “Why do cancers have high aerobic glycolysis?” Nature Reviews Cancer, vol. 4, no. 11, pp. 891–899, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-W. Kim and C. V. Dang, “Cancer's molecular sweet tooth and the warburg effect,” Cancer Research, vol. 66, no. 18, pp. 8927–8930, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. M. G. V. Heiden, L. C. Cantley, and C. B. Thompson, “Understanding the warburg effect: the metabolic requirements of cell proliferation,” Science, vol. 324, no. 5930, pp. 1029–1033, 2009. View at Publisher · View at Google Scholar
  15. J. G. Rajendran, D. A. Mankoff, F. O'Sullivan et al., “Hypoxia and glucose metabolism in malignant tumors: evaluation by [ 18F]Fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging,” Clinical Cancer Research, vol. 10, no. 7, pp. 2245–2252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Pugachev, S. Ruan, S. Carlin et al., “Dependence of FDG uptake on tumor microenvironment,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 2, pp. 545–553, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Zimny, B. Gagel, E. DiMartino et al., “FDG—a marker of tumour hypoxia? A comparison with [18F] fluoromisonidazole and pO2-polarography in metastatic head and neck cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 12, pp. 1426–1431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Buchmann, U. Haberkorn, I. Schmidtmann et al., “Influence of cell proportions and proliferation rates on FDG uptake in squamous-cell esophageal carcinoma: a PET study,” Cancer Biotherapy and Radiopharmaceuticals, vol. 23, no. 2, pp. 172–180, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Dierckx and C. van de Wiele, “FDG uptake, a surrogate of tumour hypoxia?” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 8, pp. 1544–1549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Vesselle, A. Salskov, E. Turcotte et al., “Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index,” Journal of Thoracic Oncology, vol. 3, no. 9, pp. 971–978, 2008. View at Publisher · View at Google Scholar
  21. J. Jeong, K. I. Shoghi, and J. O. Deasy, “Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response,” Physics in Medicine and Biology, vol. 58, no. 14, pp. 4897–4919, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. K. L. Kiran, D. Jayachandran, and S. Lakshminarayanan, “Mathematical modelling of avascular tumour growth based on diffusion of nutrients and its validation,” The Canadian Journal of Chemical Engineering, vol. 87, no. 5, pp. 732–740, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Hemmings, “The elaboration of a critical framework for understanding cancer: the cancer stem cell hypothesis,” Pathology, vol. 42, no. 2, pp. 105–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Chan, M. Koritzinsky, H. Zhao et al., “Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance,” Cancer Research, vol. 68, no. 2, pp. 605–614, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. I. E. M. Wijffels, H. A. M. Marres, J. P. W. Peters, P. F. J. W. Rijken, A. J. van der Kogel, and J. H. A. M. Kaanders, “Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas,” Oral Oncology, vol. 44, no. 4, pp. 335–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. B. G. Wouters and J. M. Brown, “Cells at intermediate oxygen levels can be more important than the “hypoxic fraction” in determining tumor response to fractionated radiotherapy,” Radiation Research, vol. 147, no. 5, pp. 541–550, 1997. View at Publisher · View at Google Scholar · View at Scopus